US Patent 7666874 Pyrimidylaminobenzamide derivatives for hypereosinophilic syndrome
Patent 7666874 was granted and assigned to Novartis on February, 2010 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 7666874 Pyrimidylaminobenzamide derivatives for hypereosinophilic syndrome
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
